AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.

Core Insights - AbbVie has commenced construction of a $70 million expansion at its AbbVie Bioresearch Center in Worcester, Massachusetts, as part of a broader commitment to invest over $10 billion in the U.S. to enhance biologics manufacturing capabilities [1][2][3] Group 1: Investment and Expansion - The expansion aims to increase AbbVie's domestic biologics manufacturing capacity to meet rising global demand, particularly for oncology and immunology medicines [2][3] - The project will include new biologics manufacturing areas and a three-story building for laboratory, warehouse, and office space, facilitating the transfer of select oncology products from Europe to the U.S. [2][3] Group 2: Employment and Economic Impact - AbbVie employs 28,000 people across the U.S., with over 2,000 in Massachusetts, and the expansion is expected to create new jobs at the ABC site [3] - The U.S. manufacturing footprint of AbbVie supports more than 6,000 American jobs across 11 manufacturing sites [3] Group 3: Company Mission and Focus - AbbVie's mission is to discover and deliver innovative medicines addressing serious health issues, focusing on therapeutic areas such as immunology, oncology, neuroscience, and eye care [4]